{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33406112",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e0245164",
      "10.1371/journal.pone.0245164"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "1",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).",
    "Pagination": {
      "StartPage": "e0245164",
      "MedlinePgn": "e0245164"
    },
    "Abstract": {
      "AbstractText": [
        "Rapid diagnosis is an important intervention in managing the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) outbreak. Real time reverse transcription polymerase chain reaction (RT-qPCR) remains the primary means for diagnosing the new virus strain but it is time consuming and costly. Recombinase polymerase amplification (RPA) is an isothermal amplification assay that does not require a PCR machine. It is an affordable, rapid, and simple assay. In this study, we developed and optimized a sensitive reverse transcription (RT)-RPA assay for the rapid detection of SARS-CoV-2 using SYBR Green I and/or lateral flow (LF) strip. The analytical sensitivity and specificity of the RT-RPA assay were tested by using 10-fold serial diluted synthetic RNA and genomic RNA of similar viruses, respectively. Clinical sensitivity and specificity of the RT-RPA assay were carried out using 78 positive and 35 negative nasopharyngeal samples. The detection limit of both RPA and RT-qPCR assays was 7.659 and 5 copies/\u03bcL RNA, respectively with no cross reactivity with other viruses. The clinical sensitivity and specificity of RT-RPA were 98% and 100%, respectively. Our study showed that RT-RPA represents a viable alternative to RT-qPCR for the detection of SARS-CoV-2, especially in areas with limited infrastructure."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-2037-2165"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Lau",
        "ForeName": "Yee Ling",
        "Initials": "YL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Hospital Sungai Buloh, Selangor, Malaysia."
          }
        ],
        "LastName": "Ismail",
        "ForeName": "Ilyiana Binti",
        "Initials": "IB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Hospital Sungai Buloh, Selangor, Malaysia."
          }
        ],
        "LastName": "Mustapa",
        "ForeName": "Nur Izati Binti",
        "Initials": "NIB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Lai",
        "ForeName": "Meng Yee",
        "Initials": "MY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Hospital Sungai Buloh, Selangor, Malaysia."
          }
        ],
        "LastName": "Tuan Soh",
        "ForeName": "Tuan Suhaila",
        "Initials": "TS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Hospital Sungai Buloh, Selangor, Malaysia."
          }
        ],
        "LastName": "Haji Hassan",
        "ForeName": "Afifah",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Research Centre, Hospital Sungai Buloh, Selangor, Malaysia."
          }
        ],
        "LastName": "Peariasamy",
        "ForeName": "Kalaiarasu M",
        "Initials": "KM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Research Centre, Hospital Sungai Buloh, Selangor, Malaysia."
          }
        ],
        "LastName": "Lee",
        "ForeName": "Yee Leng",
        "Initials": "YL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Abdul Kahar",
        "ForeName": "Maria Kahar Bador",
        "Initials": "MKB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Chong",
        "ForeName": "Jennifer",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute for Clinical Research (ICR), National Institutes of Health (NIH), Ministry of Health Malaysia, Putrajaya, Malaysia."
          }
        ],
        "LastName": "Goh",
        "ForeName": "Pik Pin",
        "Initials": "PP"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Recombinases"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "PLoS One. 2021 Mar 18;16(3):e0249100",
      "PMID": "33735245"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "genetics"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Malaysia"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Nucleic Acid Amplification Techniques"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Real-Time Polymerase Chain Reaction"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Recombinases"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Reverse Transcription"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ],
  "CoiStatement": "The authors have declared that no competing interests exist."
}